Prospect of Sodium–Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes

Prospect of Sodium–Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes

Sodium–glucose co-transporter 2 (SGLT2) inhibitors are a new family of antidiabetic drugs that reduce blood glucose independent of insulin. In this review, we present the advantages and adverse effects of SGLT2 inhibitors plus insulin therapy as a treatment regimen for patients with type 2 diabetes...

Full description

Bibliographic Details
Main Authors: Yinqiu Yang, Chenhe Zhao, Yangli Ye, Mingxiang Yu, Xinhua Qu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Endocrinology
Subjects:
insulin
sodium–glucose co-transporter 2 inhibitor
type 2 diabetes
combination therapy
hyperglycemia
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2020.00190/full

Similar Items

Similar Items